Financhill
Sell
20

CTTH Quote, Financials, Valuation and Earnings

Last price:
$0.0300
Seasonality move :
12.31%
Day range:
$0.0313 - $0.0313
52-week range:
$0.0170 - $0.1518
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.71x
Volume:
2.4K
Avg. volume:
124K
1-year change:
-54.01%
Market cap:
$1.8M
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTTH
CTT Pharmaceutical Holdings
-- -- -- -- --
BLMH
Blum Holdings
-- -- -- -- --
HEWA
HealthWarehouse.com
-- -- -- -- --
SNYR
Synergy CHC
-- -- -- -- --
SSY
SunLink Health Systems
-- -- -- -- --
WBA
Walgreens Boots Alliance
$36.7B $0.34 1.6% -14.63% $11.93
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTTH
CTT Pharmaceutical Holdings
$0.0313 -- $1.8M -- $0.00 0% --
BLMH
Blum Holdings
$0.61 -- $5.9M -- $0.00 0% 0.49x
HEWA
HealthWarehouse.com
$0.15 -- $8.4M -- $0.00 0% 0.25x
SNYR
Synergy CHC
-- -- -- -- $0.00 0% --
SSY
SunLink Health Systems
$1.00 -- $7M 4.17x $0.00 0% 0.23x
WBA
Walgreens Boots Alliance
$11.52 $11.93 $10B -- $0.25 8.68% 0.06x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTTH
CTT Pharmaceutical Holdings
-- 2.631 -- --
BLMH
Blum Holdings
-52.73% -0.570 285.26% 0.04x
HEWA
HealthWarehouse.com
-103.33% 0.030 119.33% 0.32x
SNYR
Synergy CHC
-- 0.000 -- --
SSY
SunLink Health Systems
-- -0.359 -- 2.97x
WBA
Walgreens Boots Alliance
50.63% -0.434 74.63% 0.29x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTTH
CTT Pharmaceutical Holdings
-- -- -- -- -- --
BLMH
Blum Holdings
$2.4M -$1.8M -- -- -58% --
HEWA
HealthWarehouse.com
$3.8M $137.7K -- -- 1.49% $153.8K
SNYR
Synergy CHC
-- -- -- -- -- --
SSY
SunLink Health Systems
$2.7M -$683K 12.24% 12.24% -9.33% -$654K
WBA
Walgreens Boots Alliance
$6.5B $13M -33.02% -58.91% 0.13% $336M

CTT Pharmaceutical Holdings vs. Competitors

  • Which has Higher Returns CTTH or BLMH?

    Blum Holdings has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -76.63%. CTT Pharmaceutical Holdings's return on equity of -- beat Blum Holdings's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings
    -- -- --
    BLMH
    Blum Holdings
    56.1% -$0.40 -$18.3M
  • What do Analysts Say About CTTH or BLMH?

    CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Blum Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than Blum Holdings, analysts believe CTT Pharmaceutical Holdings is more attractive than Blum Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings
    0 0 0
    BLMH
    Blum Holdings
    0 0 0
  • Is CTTH or BLMH More Risky?

    CTT Pharmaceutical Holdings has a beta of 0.815, which suggesting that the stock is 18.482% less volatile than S&P 500. In comparison Blum Holdings has a beta of 2.692, suggesting its more volatile than the S&P 500 by 169.15%.

  • Which is a Better Dividend Stock CTTH or BLMH?

    CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Blum Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Blum Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or BLMH?

    CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Blum Holdings quarterly revenues of $4.4M. CTT Pharmaceutical Holdings's net income of -- is lower than Blum Holdings's net income of -$3.3M. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Blum Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.49x for Blum Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings
    -- -- -- --
    BLMH
    Blum Holdings
    0.49x -- $4.4M -$3.3M
  • Which has Higher Returns CTTH or HEWA?

    HealthWarehouse.com has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of 0.82%. CTT Pharmaceutical Holdings's return on equity of -- beat HealthWarehouse.com's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings
    -- -- --
    HEWA
    HealthWarehouse.com
    42% -$0.00 -$2.1M
  • What do Analysts Say About CTTH or HEWA?

    CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand HealthWarehouse.com has an analysts' consensus of -- which suggests that it could grow by 330.75%. Given that HealthWarehouse.com has higher upside potential than CTT Pharmaceutical Holdings, analysts believe HealthWarehouse.com is more attractive than CTT Pharmaceutical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings
    0 0 0
    HEWA
    HealthWarehouse.com
    0 0 0
  • Is CTTH or HEWA More Risky?

    CTT Pharmaceutical Holdings has a beta of 0.815, which suggesting that the stock is 18.482% less volatile than S&P 500. In comparison HealthWarehouse.com has a beta of 0.238, suggesting its less volatile than the S&P 500 by 76.213%.

  • Which is a Better Dividend Stock CTTH or HEWA?

    CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthWarehouse.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. HealthWarehouse.com pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or HEWA?

    CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than HealthWarehouse.com quarterly revenues of $9M. CTT Pharmaceutical Holdings's net income of -- is lower than HealthWarehouse.com's net income of $73.8K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while HealthWarehouse.com's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.25x for HealthWarehouse.com. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings
    -- -- -- --
    HEWA
    HealthWarehouse.com
    0.25x -- $9M $73.8K
  • Which has Higher Returns CTTH or SNYR?

    Synergy CHC has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of --. CTT Pharmaceutical Holdings's return on equity of -- beat Synergy CHC's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings
    -- -- --
    SNYR
    Synergy CHC
    -- -- --
  • What do Analysts Say About CTTH or SNYR?

    CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than Synergy CHC, analysts believe CTT Pharmaceutical Holdings is more attractive than Synergy CHC.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings
    0 0 0
    SNYR
    Synergy CHC
    0 0 0
  • Is CTTH or SNYR More Risky?

    CTT Pharmaceutical Holdings has a beta of 0.815, which suggesting that the stock is 18.482% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CTTH or SNYR?

    CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or SNYR?

    CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Synergy CHC quarterly revenues of --. CTT Pharmaceutical Holdings's net income of -- is lower than Synergy CHC's net income of --. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings
    -- -- -- --
    SNYR
    Synergy CHC
    -- -- -- --
  • Which has Higher Returns CTTH or SSY?

    SunLink Health Systems has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -9.16%. CTT Pharmaceutical Holdings's return on equity of -- beat SunLink Health Systems's return on equity of 12.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings
    -- -- --
    SSY
    SunLink Health Systems
    37.14% -$0.10 $13.4M
  • What do Analysts Say About CTTH or SSY?

    CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than SunLink Health Systems, analysts believe CTT Pharmaceutical Holdings is more attractive than SunLink Health Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings
    0 0 0
    SSY
    SunLink Health Systems
    0 0 0
  • Is CTTH or SSY More Risky?

    CTT Pharmaceutical Holdings has a beta of 0.815, which suggesting that the stock is 18.482% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.109, suggesting its more volatile than the S&P 500 by 10.867%.

  • Which is a Better Dividend Stock CTTH or SSY?

    CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or SSY?

    CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than SunLink Health Systems quarterly revenues of $7.3M. CTT Pharmaceutical Holdings's net income of -- is lower than SunLink Health Systems's net income of -$671K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is 4.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.23x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings
    -- -- -- --
    SSY
    SunLink Health Systems
    0.23x 4.17x $7.3M -$671K
  • Which has Higher Returns CTTH or WBA?

    Walgreens Boots Alliance has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -0.45%. CTT Pharmaceutical Holdings's return on equity of -- beat Walgreens Boots Alliance's return on equity of -58.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings
    -- -- --
    WBA
    Walgreens Boots Alliance
    16.69% -$0.20 $14.7B
  • What do Analysts Say About CTTH or WBA?

    CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of $11.93 which suggests that it could grow by 3.54%. Given that Walgreens Boots Alliance has higher upside potential than CTT Pharmaceutical Holdings, analysts believe Walgreens Boots Alliance is more attractive than CTT Pharmaceutical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings
    0 0 0
    WBA
    Walgreens Boots Alliance
    1 12 0
  • Is CTTH or WBA More Risky?

    CTT Pharmaceutical Holdings has a beta of 0.815, which suggesting that the stock is 18.482% less volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.778, suggesting its less volatile than the S&P 500 by 22.237%.

  • Which is a Better Dividend Stock CTTH or WBA?

    CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 8.68% to investors and pays a quarterly dividend of $0.25 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or WBA?

    CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Walgreens Boots Alliance quarterly revenues of $39B. CTT Pharmaceutical Holdings's net income of -- is lower than Walgreens Boots Alliance's net income of -$175M. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings
    -- -- -- --
    WBA
    Walgreens Boots Alliance
    0.06x -- $39B -$175M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock